1. Abelman WH (1988) Myocarditis as a cause of dilated cardiomyopathy. In: Engelmeier BS, O’Connel JB (eds) Drug therapy in dilated cardiomyopathy and myocarditis. Marcel Dekker, New York, pp 221–231
2. Charlap S, Lichstein E, Frishman WH (1989) β-Adrenergic blocking drugs in the treatment of congestive heart failure. Med Clin North Am 73: 373–385
3. Engelmeier RS, O’Connel JB, Walsh R, Rad N, Scanlon PJ, Gunnar RM (1985) Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation 72: 536–546
4. Eschenhagen T, Mende U, Diederich M, Nose M, Schmitz W, Scholz H, Schulte Am Esch J, Warnholtz A, Schäfer H (1992) Long term β-adrenoceptor-mediated up-regulation of Gi± and Go± mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. Mol Pharmacol 42: 773–783
5. Francis GS, Goldsmith SR, Olivari MT, Levin TB, Cohn JN (1984) The neuronal humoral axis in congestive heart failure. Ann Intern Med 101: 370–377